Wednesday, January 14, 2004 2:37:33 AM
First I would split DNAP into two companies, one would have DNAWitness and Ancestry (maybe they could put this in CMIH) and the other would have all the medical products they are working on. I would then merge the medical side with a small drug company.
XKEM is sitting out there with problems, but they have a cancer fighting drug paclitaxel and another in the pipeline for sickle cell leukemia. The following link shows some of its promise.
http://ragingbull.lycos.com/mboard/boards.cgi?board=XKEM&read=1360
On the down side of this is that XKEM has been a bigger disappointment then DNAP.
Jim
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM